Interleukin-2 biosimilar (Laboratorio Varifarma)

重组人白细胞介素-2生物类似药 (Laboratorio Varifarma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-2 biosimilar (Laboratorio Varifarma)
Drug Alias Name重组人白细胞介素-2生物仿制药 (Laboratorio Varifarma)Interleukina-2 recombinantIlcass
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryArgentina
Original Approved Date2011/01/01
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorio Varifarma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorio Varifarma
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL03AC01
Related LinksN/A